Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma. A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

BACKGROUND: To determine if amifostine is effective in reducing the toxicities associated with the administration of platinum-containing regimens in children with hepatoblastoma (HB). METHODS: Patients were enrolled on P9645 beginning in March of 1999. Stage I/II patients received treatment with 4 c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Katzenstein, H.M., Chang, K.W., Krailo, M., Chen, Z., Finegold, M.J., Rowland, J., Reynolds, M., Pappo, A., London, W.B., Malogolowkin, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2795100/
https://ncbi.nlm.nih.gov/pubmed/19813275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24667
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg